Temporary class drug order on methiopropamine.
- Document type
- Iversen, Les
- Advisory Council on the Misuse of Drugs
- Date of publication
- 30 September 2016
- Substance Misuse, Health Services
- Social welfare
- Material type
Download (77KB )
This policy briefing recommends that the TCDO for methiopropamine (MPA) is remade for up to a further 12-month period at its expiry (to expire 26 November 2017) to allow time to gather and consider more evidence to make a substantiated recommendation.The author states that TCDO action and TCDO-related offences remain proportionate and necessary whilst this further evidence is gathered. He considers that TCDO has been effective in halting the problematic proliferation of MPA. However, he cannot substantiate a recommendation for full control under the Misuse of Drugs Act 1971 at this stage due to lack of sufficient evidence to show that the level of misuse is capable of having harmful effects sufficient to constitute a social problem. He claims that to do so would be a disproportionate response to the current evidence available, explaining the scientific and legal reasons for these suggestions and the physiological effects of abuse of MPA.
Related to Substance Misuse
Plans to reduce smoking in England
Downloadable guidelines on treating people with drug misuse and drug dependence problems
The family drug and alcohol court (FDAC) offers an alternative form of care proceedings for children put at risk of significant…
This addendum recommends revisions to the regulations regarding the scheduling of synthetic cannabinoids. Specifically, they…